跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 546 条关于
“KAT6A degrader”
全部
546
临床试验
35
药物
219
机构
3
资讯
289
9天前
FDA Clears IND for Prelude Therapeutics' First-in-Class Oral KAT6A Degrader PRT13722 in HR+/HER2- Breast Cancer
11个月前
Protai Advances AI-Driven Drug Discovery with Novel TNFα Targeting and Protein Degradation Technologies
去年
Pfizer Advances Australian-Discovered KAT6 Inhibitor PF-07248144 to Phase 3 Trial for HR+/HER2- Metastatic Breast Cancer
2年前
Prelude Therapeutics' PRT3789 Shows Promise in SMARCA4-Mutated Cancers
11个月前
Foghorn Therapeutics Reports Breakthrough Progress in Selective ARID1B Degrader for Cancer Treatment
去年
Nurix Therapeutics Advances Bexobrutideg Phase III Program and Expands Protein Degrader Pipeline
11个月前
Orum Therapeutics Strengthens Degrader-Antibody Conjugate Platform with Key Executive Appointment
去年
Nurix Therapeutics' BTK Degrader Shows Promise in Clinical Trials
去年
Proxygen Partners with EPFL to Advance AI-Driven Molecular Glue Degrader Discovery
去年
GlycoEra Secures $130M Series B to Advance Precision Protein Degrader for Autoimmune Diseases
第 1 页,共 29 页
上一页
下一页